Literature DB >> 35835509

Balancing the scales: fine-tuning Polo-like kinase 4 to ensure proper centriole duplication.

John M Ryniawec1, Gregory C Rogers1.   

Abstract

Polo-like kinase 4 (Plk4) is the master regulator of centriole assembly. Several evolutionarily conserved mechanisms strictly regulate Plk4 abundance and activity to ensure cells maintain a proper number of centrioles. In this issue of Genes & Development, Phan et al. (pp. 718-736) add to this growing list by describing a new mechanism of control that restricts Plk4 translation through competitive ribosome binding at upstream open reading frames (uORFs) in the mature Plk4 mRNA. Fascinatingly, this mechanism is especially critical in the development of primordial germ cells in mice that are transcriptionally hyperactive and thus exquisitely sensitive to Plk4 mRNA regulation.
© 2022 Ryniawec and Rogers; Published by Cold Spring Harbor Laboratory Press.

Entities:  

Keywords:  Polo-like kinase 4; centriole amplification; primordial germ cell; translational regulation; upstream open reading frame

Mesh:

Substances:

Year:  2022        PMID: 35835509      PMCID: PMC9296006          DOI: 10.1101/gad.349815.122

Source DB:  PubMed          Journal:  Genes Dev        ISSN: 0890-9369            Impact factor:   12.890


  14 in total

1.  Autoinhibition and relief mechanism for Polo-like kinase 4.

Authors:  Joseph E Klebba; Daniel W Buster; Tiffany A McLamarrah; Nasser M Rusan; Gregory C Rogers
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

Review 2.  Emerging insights into symmetry breaking in centriole duplication: updated view on centriole duplication theory.

Authors:  Shohei Yamamoto; Daiju Kitagawa
Journal:  Curr Opin Struct Biol       Date:  2020-09-18       Impact factor: 6.809

3.  Upstream open reading frames control PLK4 translation and centriole duplication in primordial germ cells.

Authors:  Thao P Phan; Christina A Boatwright; Chelsea G Drown; Marnie W Skinner; Margaret A Strong; Philip W Jordan; Andrew J Holland
Journal:  Genes Dev       Date:  2022-06-30       Impact factor: 12.890

4.  Hypoxia Drives Centrosome Amplification in Cancer Cells via HIF1α-dependent Induction of Polo-Like Kinase 4.

Authors:  Karuna Mittal; Jaspreet Kaur; Shaligram Sharma; Nivya Sharma; Guanhao Wei; Ishita Choudhary; Precious Imhansi-Jacob; Nagini Maganti; Shrikant Pawar; Padmashree Rida; Michael S Toss; Mohammed Aleskandarany; Emiel A Janssen; Håvard Søiland; Meenakshi V Gupta; Michelle D Reid; Emad A Rakha; Ritu Aneja
Journal:  Mol Cancer Res       Date:  2022-04-01       Impact factor: 6.333

5.  Identification and assessment of PLK1/2/3/4 in lung adenocarcinoma and lung squamous cell carcinoma: Evidence from methylation profile.

Authors:  Sisi Deng; Xiaoli Lu; Zhi Zhang; Rui Meng; Mi Li; Shilin Xia
Journal:  J Cell Mol Med       Date:  2021-06-02       Impact factor: 5.310

6.  The Protein Phosphatase 2A regulatory subunit Twins stabilizes Plk4 to induce centriole amplification.

Authors:  Christopher W Brownlee; Joey E Klebba; Daniel W Buster; Gregory C Rogers
Journal:  J Cell Biol       Date:  2011-10-10       Impact factor: 10.539

7.  A homeostatic clock sets daughter centriole size in flies.

Authors:  Mustafa G Aydogan; Alan Wainman; Saroj Saurya; Thomas L Steinacker; Anna Caballe; Zsofia A Novak; Janina Baumbach; Nadine Muschalik; Jordan W Raff
Journal:  J Cell Biol       Date:  2018-03-02       Impact factor: 10.539

8.  Polo-like kinase 4 kinase activity limits centrosome overduplication by autoregulating its own stability.

Authors:  Andrew J Holland; Weijie Lan; Sherry Niessen; Heather Hoover; Don W Cleveland
Journal:  J Cell Biol       Date:  2010-01-25       Impact factor: 10.539

9.  Transient PLK4 overexpression accelerates tumorigenesis in p53-deficient epidermis.

Authors:  Özdemirhan Serçin; Jean-Christophe Larsimont; Andrea E Karambelas; Veronique Marthiens; Virginie Moers; Bram Boeckx; Marie Le Mercier; Diether Lambrechts; Renata Basto; Cédric Blanpain
Journal:  Nat Cell Biol       Date:  2015-11-23       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.